Skip to main content

Table 2 Cumulative incidence of HCC in different patient groups stratified by IL-17 and AFP concentrations

From: Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

  IL-17 AFP
Cutoff Cumulative incidence at year Cutoff Cumulative incidence at year
(pg/ml) 1 2 3 4 (ng/ml) 1 2 3 4
 < Median  < 455 0.000 0.035 0.045 0.050  < 3.9 0.000 0.025 0.035 0.045
 ≥ Median  ≥ 455 0.059 0.079 0.113 0.126  ≥ 3.9 0.059 0.089 0.123 0.128
Tertile 1  < 140 0.000 0.015 0.022 0.022  < 3 0.000 0.029 0.037 0.051
Tertile 2  < 1105 0.015 0.067 0.096 0.111  < 4.9 0.015 0.037 0.059 0.059
Tertile 3  ≥ 1105 0.076 0.089 0.119 0.126  ≥ 4.9 0.076 0.106 0.144 0.152
Quartile 1  < 20 0.000 0.020 0.029 0.029  < 2.7 0.000 0.020 0.030 0.050
Quartile 2  < 455 0.000 0.051 0.061 0.071  < 3.9 0.000 0.030 0.040 0.040
Quartile 3  < 1850 0.029 0.069 0.098 0.108  < 6 0.029 0.049 0.078 0.078
Quartile 4  ≥ 1850 0.090 0.089 0.129 0.143  ≥ 6 0.090 0.130 0.170 0.180